FAQ
Drugs

If the drugs for investigational drug or active control/concomitant drug use have not been approved for marketing in Taiwan, are the certificates of analysis of drug substance, drug product and placebo/active control/concomitant drug submitted in an investigational new drug (IND) application?

刊登日期:2019-11-11  |  點閱次數 : 706 次 

Yes, the certificates of analysis of drug substance, drug product and placebo/active control/concomitant drug should be provided in the IND application.

 

(中文版)


上一筆 How many stability batches of investigational drug are required in an investigati
下一筆 Are stability data required for the submission of an investigational new drug (IN